tiprankstipranks
Trending News
More News >
Spero Therapeutics Inc (SPRO)
NASDAQ:SPRO

Spero Therapeutics (SPRO) Revenue

Compare
584 Followers

Spero Therapeutics Revenue

Spero Therapeutics had a revenue of 3.05M in the quarter ending Sep 30, 2025, with -74.17%. This bring the company's revenue in the last twelve months to 35.77M, Increased -22.56%. In the fiscal year ending Dec 31, 2024, Spero Therapeutics had annual revenue of 47.98M with -53.77% growth.
Revenue (ttm)
35.77M
Revenue Growth
-67.38%
P/S Ratio
2.69
Revenue/Employee
$1,499,281
Employees
32
Market Cap
$129.02M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
47.98M-55.80M-53.77%
Dec 31, 2023
103.78M55.20M+113.63%
Dec 31, 2022
48.58M45.51M+1,482.38%
Mar 31, 2022
3.07M-6.26M-67.10%
Dec 31, 2020
9.33M-8.82M-48.59%
Dec 31, 2019
18.15M14.18M+357.56%
Dec 31, 2018
3.97M1.99M+100.40%
Dec 31, 2017
1.98M